Consistent with this finding, increased expression of PLEKHA4 was observed in 90% (36/40) of glioma tissues compared with that normal brain tissue samples by IHC (Figures 2(c)–2(f)). This evidence concerns the gene PLEKHA4 and central nervous system cancer.